1466 related articles for article (PubMed ID: 33661990)
1. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera.
Ha B; Jadhao S; Hussaini L; Gibson T; Stephens K; Salazar L; Ciric C; Taylor M; Rouphael N; Edupuganti S; Rostad CA; Tompkins SM; Anderson EJ; Anderson LJ
Microbiol Spectr; 2021 Oct; 9(2):e0045821. PubMed ID: 34494855
[TBL] [Abstract][Full Text] [Related]
3. Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays.
Bohn MK; Hall A; Wilson S; Taher J; Sepiashvili L; Adeli K
Clin Chem Lab Med; 2021 May; 59(6):e235-e237. PubMed ID: 33577725
[No Abstract] [Full Text] [Related]
4. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.
Infantino M; Grossi V; Lari B; Bambi R; Perri A; Manneschi M; Terenzi G; Liotti I; Ciotta G; Taddei C; Benucci M; Casprini P; Veneziani F; Fabbri S; Pompetti A; Manfredi M
J Med Virol; 2020 Sep; 92(9):1671-1675. PubMed ID: 32330291
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
[TBL] [Abstract][Full Text] [Related]
6. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies.
Solastie A; Virta C; Haveri A; Ekström N; Kantele A; Miettinen S; Lempainen J; Jalkanen P; Kakkola L; Dub T; Julkunen I; Melin M
Microbiol Spectr; 2021 Dec; 9(3):e0113121. PubMed ID: 34787485
[TBL] [Abstract][Full Text] [Related]
7. Clinical Performance of SARS-CoV-2 IgG and IgM Tests Using an Automated Chemiluminescent Assay.
Zhou JA; Zeng HL; Deng LY; Li HJ
Curr Med Sci; 2021 Apr; 41(2):318-322. PubMed ID: 33877548
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
[TBL] [Abstract][Full Text] [Related]
9. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
10. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
Jalkanen P; Pasternack A; Maljanen S; Melén K; Kolehmainen P; Huttunen M; Lundberg R; Tripathi L; Khan H; Ritvos MA; Naves R; Haveri A; Österlund P; Kuivanen S; Jääskeläinen AJ; Kurkela S; Lappalainen M; Rantasärkkä K; Vuorinen T; Hytönen J; Waris M; Tauriainen S; Ritvos O; Kakkola L; Julkunen I
J Infect Dis; 2021 Jul; 224(2):218-228. PubMed ID: 33905505
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
Front Public Health; 2020; 8():620222. PubMed ID: 33681115
[No Abstract] [Full Text] [Related]
12. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
[TBL] [Abstract][Full Text] [Related]
13. Back to normal; serological testing for COVID-19 diagnosis unveils missed infections.
Tsuchida T; Nitahara Y; Suzuki S; Komase Y; Candray K; Kido Y; Nakagama Y; Yamasaki Y; Imamura M; Kawahata K; Kunishima H; Fujitani S; Mineshita M; Matsuda T
J Med Virol; 2021 Jul; 93(7):4549-4552. PubMed ID: 33739483
[TBL] [Abstract][Full Text] [Related]
14. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay.
Pieri M; Nuccetelli M; Nicolai E; Sarubbi S; Grelli S; Bernardini S
J Med Virol; 2021 Apr; 93(4):2523-2528. PubMed ID: 33463719
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
[TBL] [Abstract][Full Text] [Related]
16. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
[TBL] [Abstract][Full Text] [Related]
17. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
18. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics.
Padoan A; Cosma C; Sciacovelli L; Faggian D; Plebani M
Clin Chem Lab Med; 2020 Jun; 58(7):1081-1088. PubMed ID: 32301749
[TBL] [Abstract][Full Text] [Related]
19. Development of a quantitative COVID-19 multiplex assay and its use for serological surveillance in a low SARS-CoV-2 incidence community.
Guarino C; Larson E; Babasyan S; Rollins A; Joshi LR; Laverack M; Parrilla L; Plocharczyk E; Diel DG; Wagner B
PLoS One; 2022; 17(1):e0262868. PubMed ID: 35061843
[TBL] [Abstract][Full Text] [Related]
20. IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays.
Shah J; Liu S; Potula HH; Bhargava P; Cruz I; Force D; Bazerbashi A; Ramasamy R
BMC Infect Dis; 2021 Apr; 21(1):325. PubMed ID: 33827460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]